Suppr超能文献

自身免疫性多内分泌腺综合征 1 型(APECED)在印度人群中的表现:病例报告及对 45 例患者系列的回顾。

Autoimmune polyendocrine syndrome type 1 (APECED) in the Indian population: case report and review of a series of 45 patients.

机构信息

Infectivology and Clinical Trials Research Department, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Laboratory Medicine, Department of Medicine (DIMED), University of Padua, Padua, Italy.

出版信息

J Endocrinol Invest. 2021 Apr;44(4):661-677. doi: 10.1007/s40618-020-01376-5. Epub 2020 Aug 7.

Abstract

BACKGROUND

Autoimmune polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) or autoimmune polyglandular syndrome type 1 (APS-1) is a rare autosomal recessive genetic disease due to mutations in the AIRE (AutoImmune REgulator) gene. The clinical diagnosis is classically based on the presence of at least two of the three main components: chronic mucocutaneous candidiasis, hypoparathyroidism and primary adrenal insufficiency. Patients often suffer from other endocrine or non-endocrine autoimmune conditions throughout life. APECED etiopathogenesis is mediated by T lymphocytes. Autoantibodies against proteins of the affected organs are found in the serum of APECED patients as well as neutralizing antibodies against cytokines. We report here the clinical and genetic characteristics of 45 Indian APECED patients in comparison to Finnish, Sardinian, Turkish and North/South American cohorts from their published results. We also report a new case of APECED of Indian origin, a 2-year old child suffering from chronic mucocutaneous candidiasis since the age of 8 months, with confirmatory AIRE homozygous mutation c.274C > T (p.R92W).

CONCLUSION

With the inherent limitations of a retrospective study, analysis of Indian APECED patients suggested that compared to classic criteria, application of Ferre/Lionakis criteria validated in North/South American patients could help in earlier diagnosis in 3 of 8 (37.5%) patients for whom adequate information for evaluation was available.

摘要

背景

自身免疫性多内分泌腺病-念珠菌病-外胚层营养不良(APECED)或自身免疫性多腺体综合征 1 型(APS-1)是一种罕见的常染色体隐性遗传疾病,由于 AIRE(自身免疫调节剂)基因突变所致。临床诊断经典地基于以下三个主要成分中的至少两个:慢性黏膜皮肤念珠菌病、甲状旁腺功能减退症和原发性肾上腺功能不全。患者一生中常常患有其他内分泌或非内分泌自身免疫性疾病。APECED 的发病机制是由 T 淋巴细胞介导的。APECED 患者的血清中存在针对受影响器官蛋白的自身抗体以及针对细胞因子的中和抗体。我们在此报告了 45 例印度 APECED 患者的临床和遗传特征,与芬兰、撒丁岛、土耳其和北美/南美队列的已发表结果进行了比较。我们还报告了一例新的印度起源的 APECED 病例,这是一名 2 岁的儿童,从 8 个月大开始患有慢性黏膜皮肤念珠菌病,具有可确认的 AIRE 纯合突变 c.274C > T(p.R92W)。

结论

在回顾性研究的固有局限性下,对印度 APECED 患者的分析表明,与经典标准相比,在北美/南美患者中验证的 Ferre/Lionakis 标准的应用可能有助于 8 名(37.5%)患者中的 3 名更早地诊断,这 3 名患者有足够的评估信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验